... hyposmia through impairment of odorant binding to the OR or injury to the OR (sensory hyposmia), or through neurologic impairment (neural hyposmia). Most relevant information on pharmaceuticals impacting canine olfaction is extrapolated ...
... hyposmia as a biomarker for AD. In contrast, we have utilized a much more comprehensive approach to study the neural correlates of hyposmia. If hyposmia is one of the earliest prodromal features of neurodegeneration, structural changes ...
... hyposmia, Parkinson's disease, event-related potentials, working memory, visuospatial function, language. INTRODUCTION. attention (Bleckley et al., 2003; Giuliano et al., 2014). And Hyposmia is one of the most important non-motor symptoms ...
... hyposmia are clearly differentiated from those with anosmia or type I hyposmia. They are responsive at both primary and accessory areas of olfaction, although this response is less than normal. The MDT for pyridine for this group is ...
... hyposmia . The authors found that brain activation in response to odors was present in patients with congenital hyposmia , but activation was signi- ficantly lower than in normal subjects and in patients with acquired hyposmia ...
... hyposmia, anosmia, subjective hypogeusia, no olfactory windows, phantosmia. me anisms: with no blood–brain barrier, toxins overwhelm the nasal xenobiotic me anism, inducing olfactory nerve cell death. Aluminosilicates, in addition ...